Latest Articles
- ArticleCoQ10 in progressive supranuclear palsyA randomized, placebo-controlled, double-blind trialDiana Apetauerova, Stephanie A. Scala, Robert W. Hamill, et al.August 02, 2016
- ArticleEarly indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorderRemi A. Kessler, Maureen A. Mealy, Michael LevyJuly 28, 2016
- Clinical/Scientific NotesBilateral vertebral artery occlusion without headache in giant cell arteritisPriyank Khandelwal, Hui Guan, Seemant ChaturvediJuly 28, 2016
- ArticleMRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7TTim Sinnecker, Sophie Schumacher, Katharina Mueller, et al.July 22, 2016
- ArticleLack of KIR4.1 autoantibodies in Japanese patients with MS and NMOOsamu Higuchi, Shunya Nakane, Waka Sakai, et al.July 22, 2016
- EditorialNext-generation sequencing of tissueA logical extensionJoseph R. Berger, Michael R. WilsonJuly 14, 2016
- ArticleAutoantibodies against glutamate receptor δ2 after allogenic stem cell transplantationRamona Miske, Stefanie Hahn, Thorsten Rosenkranz, et al.July 14, 2016
- ArticleNo association of tobacco use and disease activity in multiple sclerosisSilje Kvistad, Kjell-Morten Myhr, Trygve Holmøy, et al.July 14, 2016
- Clinical/Scientific NotesRituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitisBertrand Lioger, Nicole Ferreira-Maldent, Jean Philippe Cottier, et al.July 08, 2016
- ArticleInfliximab is a plausible alternative for neurologic complications of Behçet diseaseBurcu Zeydan, Ugur Uygunoglu, Sabahattin Saip, et al.July 08, 2016
Pages
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg